An approvable letter is sent by the FDA when a drugmaker's New Drug Application is not sufficient for approval, but has the potential to be approved at a later date. The letter spells out what problems the FDA had with the marketing application. Often times further meetings with the FDA are required to determine what needs to be done to get the drug approved.
Recent Mentions on Fool.com
- St. Jude Medical Inc.: In-Line Is Just Not Good Enough
- The S&P 500's 3 Biggest Biotech Losers of 2014
- Wednesday?s Top Health Care Stories: Zogenix, Endo, and Teva
- Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences Inc. for Hep C Combo?
- Tuesday?s Top Health Care Stories: Johnson & Johnson, Teva, Mylan, and Dynavax
- Can Intuitive Surgical Find New Growth?